Healthcare Sector Insights

Can the Smith & Nephew share price continue to outperform?

There's an exclusive group of stocks that most investors would love to own. These companies have stellar track records, sparkling reputations and the ability to deliver stunning returns over long periods - and Smith & Nephew (LON:SN.

Can the Smith & Nephew share price continue to outperform?

There's an exclusive group of stocks that most investors would love to own. These companies have stellar track records, sparkling reputations and the ability to deliver stunning returns over long periods - and Smith & Nephew (LON:SN.

Why Astrazeneca might be a high quality investment

A company with a high Quality Rank has strong cash-generation, consistent profits, high margins and robust financial health. Quality companies are good at reinvesting at high returns, which allows earnings (and share prices) to compound

Why the Medica share price might encounter turbulence

Stockopedia’s ‘High Flyers’ are the stock market superstars. These companies tend to be the ones that fund managers jostle and barter over. They are high quality, growing stocks with a history of beating estimates - and Medica (LON

Is Glaxosmithkline expensive at 1630p?

Glaxosmithkline (LON:GSK) is a giant of the Pharmaceuticals industry, with a market cap of £81.2bn and annual sales of c£30bn. The global healthcare company operates through three segments: Pharmaceuticals, Vaccines and Consumer H

© Stockopedia 2019, Thomson Reuters, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.